January 31, 2014

 

Bayer CropScience and Cellectis extend partnership on rapeseed traits

 

 

Bayer CropScience has signed two new agreements with Cellectis plant sciences on gene editing in plants, where the existing partnership has been extended to introduce targeted modifications to selected plant genes and genomes.

 

The first aim of this extended partnership is to collaboratively create commercial traits for the rapeseed market using new technologies developed by Cellectis plant sciences. The second aim is to provide Bayer with access to technologies that enable the directed engineering of plant genomes, such as gene stacking and targeted mutagenesis, for the development of improved crops.

 

"These novel technologies work efficiently in plant cells and will be an important tool to improve crops," said Catherine Feuillet, head of trait research at Bayer CropScience.

 

"These new agreements position Cellectis plant sciences as a key partner for Bayer CropScience," commented Luc Mathis, CEO of Cellectis plant sciences.

 

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, and is one of the world's leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control.